Who backs OrsoBio?
8 investors| Investor | Type |
|---|---|
| Samsara BioCapital | Venture capital |
| Longitude Capital | Venture capital |
| Woodline Partners | Hedge fund |
| Ascenta Capital | Venture capital |
| Eli Lilly | — |
| Enavate Sciences | — |
| National Institute of Diabetes and Digestive and Kidney Diseases | — |
| NuevaBio | — |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
OrsoBio investors
8 investors are on record for OrsoBio, including Samsara BioCapital, Longitude Capital, Woodline Partners and Ascenta Capital. The early-stage round in Aug 2024 drew 7 investors.
Free account
More of OrsoBio with a free account
- ·Watch OrsoBio: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 8 firms already write checks for companies like OrsoBio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View